跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SODIUM CHLORIDE INJECTION USP 0.45% - HSA Drug Approval Details
Approvals
/
HSA
/
SODIUM CHLORIDE INJECTION USP 0.45%
Approved
THERAPEUTIC
SODIUM CHLORIDE INJECTION USP 0.45%
BAXTER HEALTHCARE CORPORATION (UNITED STATES)
🇸🇬 Health Sciences Authority
Approval Date
Mar 2, 1992
Approval ID
ccfac52f55828928
Company
BAXTER HEALTHCARE CORPORATION (UNITED STATES)
Type
Therapeutic
Approval Details
Approval Id
ccfac52f55828928
Drug Name
SODIUM CHLORIDE INJECTION USP 0.45%
Product Name
SODIUM CHLORIDE INJECTION USP 0.45%
Approval Number
SIN06865P
Approval Date
1992-03-02
Registrant
BAXTER HEALTHCARE (ASIA) PTE LTD
Licence Holder
BAXTER HEALTHCARE (ASIA) PTE LTD
Drug Type
Therapeutic
Forensic Classification
GENERAL SALE LIST
Dosage Form
INJECTION
Route Of Administration
INTRAVENOUS
Atc Code
B05XA03
Atc Item Name
sodium chloride
Pharma Manufacturer Name
BAXTER HEALTHCARE (ASIA) PTE LTD
Company Detail Path
/organization/baxter-healthcare-asia-pte-ltd
Active Ingredients
SODIUM CHLORIDE
0.45%
SODIUM CHLORIDE
0.45%
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 2, 1992
Approval ID
ccfac52f55828928
Type
Therapeutic
Back to HSA Approvals